Low LDL Cholesterol Linked to Reduced Dementia & Alzheimer’s Risk – Study

Low LDL Cholesterol Linked to Reduced Dementia & Alzheimer’s Risk – Study

January 25, 2026 discoverhiddenusacom Health

New research suggests a connection between lower levels of LDL cholesterol – often referred to as “bad” cholesterol – and a reduced risk of dementia, including Alzheimer’s disease. The findings, stemming from an analysis of over 570,000 patients, add to a growing body of work linking cholesterol levels to neurodegenerative conditions.

A Surprising Link: Lower LDL and Brain Health

Researchers in South Korea investigated whether decreasing levels of “bad” cholesterol correlated with a lower incidence of dementia. They analyzed data from patients followed across 11 university hospitals, comparing groups with varying LDL-C levels. The study, published in The Journal of neurology, neurosurgery and psychiatry, revealed that individuals with LDL-C levels below 1.8 millimoles per liter of blood (mmol/L), or 70 mg/dl, experienced a 26% reduction in dementia risk and a 28% reduction in Alzheimer’s disease risk compared to those with levels above 3.4 mmol/L (130 mg/dl).

Did You Know? The study analyzed data from more than 570,000 patients across 11 university hospitals.

However, the protective effect diminished as LDL-C levels dropped further, disappearing entirely below 0.8 mmol/L (30 mg/dL). This suggests that extremely low levels of LDL-C do not offer additional benefits in dementia prevention.

The Role of Statins

The research also examined the impact of statins – medications used to lower cholesterol – on dementia risk. The study found that statin use reinforced the protective benefits of low LDL-C. Among patients with LDL-C levels below 1.8 mmol/L, taking statins was associated with an additional 13% reduction in dementia risk and a 12% reduction in Alzheimer’s disease risk.

Expert Insight: These findings highlight the potential importance of managing LDL cholesterol levels as part of a broader strategy for reducing dementia risk, but further research is needed to establish a definitive cause-and-effect relationship.

The study’s authors emphasize that these results underscore the crucial role of LDL cholesterol management in reducing dementia risk. They acknowledge, however, that this was an observational study and does not prove a direct causal link.

Frequently Asked Questions

What is considered a normal LDL cholesterol level?

In the absence of risk factors, a “bad” cholesterol level is considered normal when it is less than 160 mg/dl.

What were the LDL-C levels associated with reduced risk in the study?

Individuals with LDL-C levels below 1.8 mmol/L (70 mg/dl) showed a 26% reduction in dementia risk and a 28% reduction in Alzheimer’s disease risk compared to those with levels above 3.4 mmol/L (130 mg/dl).

Did the study find any downsides to very low LDL-C levels?

Yes, the study revealed that the protective effect diminished with very low LDL-C levels and disappeared completely below 0.8 mmol/L (30 mg/dL).

As research continues, will these findings influence how healthcare professionals approach cholesterol management and dementia prevention?